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Once thought to be rare, autism spectrum disorders (ASD) have
gained increasing public attention as prevalence studies have revealed
sharp increases over the past two decades. ASD now represents the
second most common category of neurodevelopmental disorders. The
prevalence data have been instrumental in mobilizing parents to act
on behalf of their affected family members for better services and
treatments and for greater research investments aimed at understand-
ing what causes these disorders and how they can be prevented.
Increased funding for ASD research has led to visible progress in
many areas, although the causes for the sharp increase in prevalence
remain unresolved. Changes in awareness, diagnostic practices, and
availability of services can account for some of the increase, yet a sep-
arate role for increased exposure to one or more environmental
agents also has been suggested. 
The increases in prevalence data also helped fuel speculation
regarding a link between the mercury-based vaccine preservative
thimerosal and ASD. Many methodologically sound epidemiologic
studies have failed to support a causal relationship. Concerns persist
for some parents, however, and current time trends remain under
scrutiny. The possibility of a small subgroup of children with a
unique vulnerability to vaccines or vaccine components has been
raised and is more difficult to address.
In light of the persistent public attention to ASD prevalence and to
vaccines as potential risk factors, it is surprising that an appreciation
for the larger fundamental question of how nongenetic/environmental
factors may contribute to ASD has grown slowly. This is unfortunate,
because a diverse spectrum of environmental factors merit considera-
tion—from pesticides and other agrichemicals to pharmaceuticals,
nutrition, and lifestyle. The full explanation for the relative lack of
attention to environmental hypotheses is complex. Contributing influ-
ences are likely to include the contemporary scientific focus on genetic
etiologies of ASD, the possible reluctance of investigators to enter an
arena that included the controversial issue of vaccines as risk factors,
the lack of strong etiologic clues to pursue, and the need to build new
investigative teams and infrastructure that can support sustained
research in this nascent area. A recent Institute of Medicine meeting
on autism and the environment (Autism and the Environment:
Challenges and Opportunities for Research, Washington, DC, 16–17
April 2007) highlighted the continuing challenges and opportunities
for research in this area (Altevogt et al. 2008). 
Despite the relatively tepid scientific interest in the environment
and autism over the past 8 years, there have been signs of progress. A
U.S. surveillance network established by the Centers for Disease
Control and Prevention (CDC) is now in place to aid detection and
interpretation of future trends (Rice et al. 2007). In 2001, a Center
for Children’s Environmental Health and Disease Prevention whose
focus is on ASD was established at the University of California-Davis
with support from the National Institute of Environmental Health
Sciences and U.S. Environmental Protection Agency. The Center
brought new investigators into the field of autism and environmental
health sciences and incorporated methods of community engage-
ment that built trust between researchers and parent advocates; this,
in turn, enriched the science being con-
ducted and enhanced the ability to dissem-
inate scientific results produced by the
studies. Interdisciplinary collaborations
among investigators at the Center make it
possible to tackle questions using multiple approaches, from human
studies to animal and cellular models.  
One key component of the University of California-Davis
Center has been the CHARGE (Childhood Autism Risks from
Genetics and the Environment) study, the first large scale popula-
tion-based case–control epidemiology study of environmental and
genetic risk factors for autism. Various environmental risk factors are
being explored, from metals and pesticides to medications and infec-
tions (Hertz-Picciotto et al. 2006). The nascent research efforts
begun in 2001 have matured and expanded; recent findings of note
support a role for immune dysregulation in ASD.
More recently, other large U.S. epidemiology studies have been
initiated that can help address the relationship between ASD and
environmental factors, including the CDC-sponsored SEED
(Studies to Explore Early Development) Study (CDC 2006). 
One of the recently awarded National Institutes of Health (NIH)
Autism Centers for Excellence (ACE) is a multisite collaborative
study led by investigators at Drexel University focused on identifying
environmental risks, biomarkers, genetic susceptibility, and
gene–environment interplay (NIH 2008). The EARLI study (Early
Autism Risk Longitudinal Investigation) will create an enriched risk
birth cohort. Mothers with one child with ASD will be enrolled at
the start of a subsequent pregnancy, and a variety of data, including
data related to environmental exposures, will be collected pre- and
postnatally to address key questions regarding etiology and natural
history of ASD. 
Perhaps the most promising indicator of future progress is evi-
dent in the recent activities of the Interagency Autism Coordinating
Committee (IACC). The IACC was reestablished as part of the 2006
Combating Autism Act and charged with developing and annually
updating a Strategic Plan for Autism Research (IACC 2007) to guide
federal efforts and encourage public–private partnerships. The
process of plan development has included gathering broad input
from various stakeholders and evaluating current research invest-
ments to identify strengths, weaknesses, and opportunities. There is
general agreement that the role of environment in ASD risk has been
neglected and merits additional emphasis. The draft version of the
plan includes several objectives that address environmental aspects of
autism. 
Finally, it is important to recognize that advances in understand-
ing environmental influences in ASD will rely on developments in
other areas. The NIH Genes, Environment and Health Initiative
(NIH 2007) should provide new tools and approaches for addressing
joint effects of genetic and environmental influences in complex dis-
orders. The growing field of epigenomics suggests new ways for the
environment to induce heritable changes in gene regulation without
altering gene sequence. Advances in stem cell biology that enable
A 416 VOLUME 116 | NUMBER 10 | October 2008 • Environmental Health Perspectives
The “Environment” for Autism Research:
Signs of Improvement?
doi:10.1289/ehp.12107
Perspectives | Editorial
Cindy P. LawlerEnvironmental Health Perspectives • VOLUME 116 | NUMBER 10 | October 2008 A 417
reprogramming of fibroblasts from individuals with complex diseases
could be used to probe susceptibility to environmental exposures dur-
ing the earliest stages of cell development. Likewise, new develop-
ments in ASD genetics, such as copy number variation, offer novel
opportunities to consider how environmental agents may influence
genomic stability. 
In summary, the “environment” for this area of research has
improved, albeit slowly. Incorporation of specific objectives target-
ing environmental risk factors in the IACC Strategic Plan, together
with clues emerging from ongoing studies and an increased recogni-
tion of the potential for identification of preventable risk factors,
should help to create a new sense of urgency to address environ-
mental hypotheses in ASD. 
This editorial is the work product of an employee of the National
Institute of Environmental Health Sciences (NIEHS), National
Institutes of Health (NIH); however, the statements, opinions, or con-
clusions contained therein do not necessarily represent the statements,
opinions, or conclusions of the NIEHS, the NIH, or the United States
government. 
Cindy P. Lawler
National Institute of Environmental Health Sciences
Division of Extramural Research and Training
Research Triangle Park, NC 
E-mail: lawler@niehs.nih.gov
Cindy Lawler is a program administrator in the Division of
Extramural Research and Training of NIEHS, with responsibility in
the area of neurotoxicology and specific interests in environmental
influences in neurodegenerative diseases such as Parkinson's disease and
neurodevelopmental disorders such as autism. She oversees the Centers
for Neurodegeneration Science (CNS) and is the NIEHS representative
to the InterAgency Autism Coordinating Committee.
REFERENCES
Altevogt BM, Hanson SL, Leshner AI. 2008. Autism and the environment: challenges and
opportunities for research. Pediatrics 121(6):1225–1229.
CDC (Centers for Disease Control and Prevention). 2006. Studies to Explore Early
Development (SEED). Available: http://www.cdc.gov/ncbddd/autism/seed.htm
[accessed 12 September 2008].
Combating Autism Act. 2006. Public Law 109-416.
Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. 2006. The
CHARGE study: an epidemiologic investigation of genetic and environmental factors
contributing to autism.Environ Health Perspect. 114:1119–1125.
IACC. 2007. Interagency Autism Coordinating Committee (IACC) Strategic Plan for Autism
Spectrum Disorder Research. Available: http://www.nimh.nih.gov/research-fund-
ing/scientific-meetings/recurring-meetings/iacc/strategic-plan/index.shtml
[accessed 9 September 2008]. 
NIH (National Institutes of Health). 2007. The Genes, Environment and Health Initiative
(GEI). Available: http://www.gei.nih.gov/ [accessed 9 September 2008]. 
NIH (National Institutes of Health). 2008. Newly Awarded Autism Centers of Excellence
to Further Autism Research. Available: http://www.nimh.nih.gov/science-
news/2008/newly-awarded-autism-centers-of-excellence-to-further-autism-
research.shtml [accessed 12 September 2008].
Rice CE, Baio J, Van Naarden Braun K, Doernberg N, Meaney FJ, Kirby RS, et al. 2007. A
public health collaboration for the surveillance of autism spectrum disorders.
Paediatr Perinat Epidemiol 21(2):179–190.
Editorial | Autism and the Environment
EHP has revised its Instructions to Authors. The new version became available on the journal’s website on 19 September 2008, and a
print version is provided on page A444. The instructions now provide background information (Who We Are) and describe the type
of multidisciplinary research of interest to the journal (What We Publish). Sections are organized to address the various phases of
publication (e.g., About Your Manuscript, Manuscript Preparation, Manuscript Submission, Publication Sequence). The instructions
also include a section on the publication style preferred by the journal (EHP Style). 
Please note that the journal remains committed to the full disclosure of all potential competing interests for authors, reviewers, and
EHP editors. For the first time, we have described EHP’s policy concerning potential nonfinancial conflicts of interest. This policy
pertains primarily to reviewers and editors. 
The new Instructions to Authors also describes in considerable detail the process for using the new Manuscript Central (ScholarOne)
tracking system that we announced in the August issue of the journal [Environ Health Perspect 116:A328 (2008)]. New manuscripts
should be submitted using this system (http://mc.manuscriptcentral.com/ehp). Authors should also note the new page charges and
costs for color figures effective 1 August 2008.
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